Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19

Clinical trial NCT05212662 · WITHDRAWN

Trial details

NCT number: NCT05212662
Sponsor: Thiogenesis Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 COVID-19 Acute Respiratory Distress Syndrome

Start date: 2024-09-27
Primary completion: 2024-09-27
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.